Dexcom Launches Inaugural Venture Capital Fund

There’s a new venture fund operating in the healthcare space.

DexCom Inc. has launched Dexcom Ventures, an inaugural fund that will identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

“Driven by core technologies that our teams have developed internally, Dexcom continues to achieve strong growth and expand our future markets,” said Kevin Sayer, chairman, president and CEO of Dexcom. “By establishing Dexcom Ventures, we believe we can advance innovative technologies that enable better health outcomes and complement our growth opportunity. I have full confidence in Steve and his team as they lead this exciting new effort.”
 
Dexcom Ventures will be led by Dexcom veteran Steve Pacelli and will be focused on investment opportunities in sensing technology, data analytics, remote patient monitoring and population health, broadening Dexcom’s commitment to advancing better outcomes in healthcare.
 
The fund will support independent initiatives in glucose sensing technologies and in adjacent fields of metabolic monitoring and marks the entrance into the venture capital space for parent company Dexcom.
 
“We strive to be value-add strategic investors by leveraging access to Dexcom’s unique industry expertise and technology leadership,” Pacelli said. “While we have matured as a company over the years, we still consider ourselves to be a ‘start-up’ of sorts. We feel well positioned to invest early and support our portfolio companies as they pioneer markets.’’

Dexcom is a global developer of continuous glucose monitoring technologies for people with diabetes.